Baxter International Inc
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable p… Read more
Baxter International Inc (BAX) - Total Assets
Latest total assets as of December 2025: $20.05 Billion USD
Based on the latest financial reports, Baxter International Inc (BAX) holds total assets worth $20.05 Billion USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Baxter International Inc - Total Assets Trend (1985–2025)
This chart illustrates how Baxter International Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Baxter International Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Baxter International Inc's total assets of $20.05 Billion consist of 34.3% current assets and 65.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.8% |
| Accounts Receivable | $1.86 Billion | 9.3% |
| Inventory | $2.23 Billion | 11.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $4.37 Billion | 21.8% |
| Goodwill | $4.93 Billion | 24.6% |
Asset Composition Trend (1985–2025)
This chart illustrates how Baxter International Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Baxter International Inc's current assets represent 34.3% of total assets in 2025, a decrease from 34.6% in 1985.
- Cash Position: Cash and equivalents constituted 9.8% of total assets in 2025, up from 4.0% in 1985.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 45.0% of total assets, an increase from 34.0% in 1985.
- Asset Diversification: The largest asset category is goodwill at 24.6% of total assets.
Baxter International Inc Competitors by Total Assets
Key competitors of Baxter International Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Baxter International Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Baxter International Inc generates 0.56x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Baxter International Inc generates $5.66 in net profit.
Baxter International Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.31 | 1.36 | 2.47 |
| Quick Ratio | 1.56 | 1.05 | 1.83 |
| Cash Ratio | 0.00 | 0.27 | 0.00 |
| Working Capital | $3.90 Billion | $ 2.34 Billion | $ 4.67 Billion |
Baxter International Inc - Advanced Valuation Insights
This section examines the relationship between Baxter International Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.33 |
| Latest Market Cap to Assets Ratio | 0.45 |
| Asset Growth Rate (YoY) | -22.2% |
| Total Assets | $20.05 Billion |
| Market Capitalization | $9.02 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Baxter International Inc's assets below their book value (0.45 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Baxter International Inc's assets decreased by 22.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Baxter International Inc (1985–2025)
The table below shows the annual total assets of Baxter International Inc from 1985 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $20.05 Billion | -22.21% |
| 2024-12-31 | $25.78 Billion | -8.82% |
| 2023-12-31 | $28.28 Billion | -0.04% |
| 2022-12-31 | $28.29 Billion | -15.61% |
| 2021-12-31 | $33.52 Billion | +67.45% |
| 2020-12-31 | $20.02 Billion | +10.04% |
| 2019-12-31 | $18.19 Billion | +15.73% |
| 2018-12-31 | $15.72 Billion | -8.13% |
| 2017-12-31 | $17.11 Billion | +10.07% |
| 2016-12-31 | $15.55 Billion | -25.84% |
| 2015-12-31 | $20.96 Billion | -19.80% |
| 2014-12-31 | $26.14 Billion | +3.62% |
| 2013-12-31 | $25.22 Billion | +23.71% |
| 2012-12-31 | $20.39 Billion | +6.91% |
| 2011-12-31 | $19.07 Billion | +9.06% |
| 2010-12-31 | $17.49 Billion | +0.78% |
| 2009-12-31 | $17.35 Billion | +12.65% |
| 2008-12-31 | $15.40 Billion | +0.73% |
| 2007-12-31 | $15.29 Billion | +4.14% |
| 2006-12-31 | $14.69 Billion | +15.39% |
| 2005-12-31 | $12.73 Billion | -10.04% |
| 2004-12-31 | $14.15 Billion | +3.21% |
| 2003-12-31 | $13.71 Billion | +9.85% |
| 2002-12-31 | $12.48 Billion | +20.64% |
| 2001-12-31 | $10.34 Billion | +18.44% |
| 2000-12-31 | $8.73 Billion | -9.45% |
| 1999-12-31 | $9.64 Billion | -2.32% |
| 1998-12-31 | $9.87 Billion | +13.39% |
| 1997-12-31 | $8.71 Billion | +14.63% |
| 1996-12-31 | $7.60 Billion | -19.51% |
| 1995-12-31 | $9.44 Billion | -5.65% |
| 1994-12-31 | $10.00 Billion | -5.15% |
| 1993-12-31 | $10.54 Billion | +15.18% |
| 1992-12-31 | $9.15 Billion | -1.98% |
| 1991-12-31 | $9.34 Billion | +9.66% |
| 1990-12-31 | $8.52 Billion | +0.16% |
| 1989-12-31 | $8.50 Billion | -0.55% |
| 1988-12-31 | $8.55 Billion | +11.94% |
| 1987-12-31 | $7.64 Billion | +8.06% |
| 1986-12-31 | $7.07 Billion | +3.35% |
| 1985-12-31 | $6.84 Billion | -- |